Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q2 2020 13F Holders as of 30 Jun 2020
- Security type / class
- Equity / Common Shares, without par value
- Total 13F shares
- 26,122,191
- Total 13F value
- $47,560,467
- Share change
- -159,572
- Put/Call ratio
- 0%
- SEC-reported price per share
- $1.82
- Number of holders
- 46
- Value change
- +$748,885
- Number of buys
- 24
- Number of sells
- 19
- Shares outstanding
- 197,420,670
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2020
Institutions
46
Top holders
10
ABUS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2020
Previous quarter: Q1 2020
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Ownership snapshot
Top reported holders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F
Lead comparable stake: 3.5%
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 3.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
3.5%
COWEN AND COMPANY, LLC
2.2%
CITADEL ADVISORS LLC
1.3%
MORGAN STANLEY
1%
GOLDMAN SACHS GROUP INC
0.98%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
Company
|
3.5%
|
$6,938,000
6,869,281 shares
|
— | 31 Mar 2020 |
| COWEN AND COMPANY, LLC |
13F
Company
|
2.2%
|
$4,374,000
4,331,020 shares
|
— | 31 Mar 2020 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.3%
|
$2,503,000
2,478,119 shares
|
— | 31 Mar 2020 |
| MORGAN STANLEY |
13F
Company
|
1%
|
$2,067,000
2,047,008 shares
|
— | 31 Mar 2020 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.98%
|
$1,958,000
1,938,329 shares
|
— | 31 Mar 2020 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
0.9%
|
$1,793,000
1,774,815 shares
|
— | 31 Mar 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
46
Shares
26,122,191
Rows available
46
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
44
Q2 2020 holders
46
Holder diff
2
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q2 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend